Apatinib as a Third-Line Treatment for HER2-Positive Metastatic Gastric Cancer: A Multi-Center Single-Arm Cohort Study

por Zhang, Xin, Huo, Haoran, Nie, Yanan, Xue, Jiadong, Yuan, Zengjiang, Zhang, Zhenyi
Publicado 2022

Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot study

por Huo, Haoran, Wang, Xiaoying, Xu, Shan, Niu, Xiaotong, Cheng, Limin, Yuan, Zengjiang, Huo, Shuang, Fang, Pingping
Publicado 2023